Two genetically-related multidrug-resistant Mycobacterium tuberculosis strains induce divergent outcomes of infection in two human macrophage models

Infection, Genetics and Evolution

Volumn 16, Issue , 2013, Pages 151-156

  Yokobori, Noemí ^a   López, Beatriz ^b   Geffner, Laura ^a   Sabio y García, Carmen ^a   Schierloh, Pablo ^a   Barrera, Lucía ^b   de la Barrera, Silvia ^a   Sakai, Shunsuke ^c   Kawamura, Ikuo ^c   Mitsuyama, Masao ^c   Ritacco, Viviana ^b   del Carmen Sasiain, María ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Cytokines; Monocyte derived macrophages; Multidrug resistance; Mycobacterium tuberculosis; U937; Virulence

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL GROWTH; CONTROLLED STUDY; CYTOKINE RESPONSE; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRASPECIFIC VARIATION; MACROPHAGE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; STRAIN DIFFERENCE;

ANALYSIS OF VARIANCE; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES; MALE; MODELS, BIOLOGICAL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84875250088     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.01.007     Document Type: Article

References (43)

1. Alonso M., Rodriguez N.A., Garzelli C., Lirola M.M., Herranz M., Samper S., Serrano M.J.R., Bouza E., Viedma D.G.D. Characterization of Mycobacterium tuberculosis Beijing isolates from the Mediterranean area. BMC Microbiol. 2010, 10:151.
2. Brites D., Gagneux S. Old and new selective pressures on Mycobacterium tuberculosis. Infect. Genet. Evol. 2011, 12:678-685.
3. Caws M., Thwaites G., Dunstan S., Hawn T.R., Lan N.T., Thuong N.T., Stepniewska K., Huyen M.N., Bang N.D., Loc T.H., Gagneux S., Van Soolingen D., Kremer K., Van der Sande M., Small P., Anh P.T., Chinh N.T., Quy H.T., Duyen N.T., Tho D.Q., Hieu N.T., Torok E., Hien T.T., Dung N.H., Nhu N.T., Duy P.M., Van Vinh Chau N., Farrar J. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 2008, 4:e1000034.
4. Chacón-Salinas R., Serafín-López J., Ramos-Payán R., Méndez-Aragón P., Hernández-Pando R., Van Soolingen D., Flores-Romo L., Estrada-Parra S., Estrada-García I. Differential pattern of cytokine expression by macrophages infected in vitro with different Mycobacterium tuberculosis genotypes. Clin. Exp. Immunol. 2005, 140:443-449.
5. Dao D.N., Sweeney K., Hsu T., Gurcha S.S., Nascimento I.P., Roshevsky D., Besra G.S., Chan J., Porcelli S.A., Jacobs W.R. Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production. PLoS Pathog. 2008, 4:e1000081.
6. Diaz-Silvestre H., Espinosa-Cueto P., Sanchez-Gonzalez A., Esparza-Ceron M.A., Pereira-Suarez A.L., Bernal-Fernandez G., Espitia C., Mancilla R. The 19-kDa antigen of Mycobacterium tuberculosis is a major adhesin that binds the mannose receptor of THP-1 monocytic cells and promotes phagocytosis of mycobacteria. Microb. Pathog. 2005, 39:97-107.
7. Dormans J., Burger M., Aguilar D., Hernandez-Pando R., Kremer K., Roholl P., Arend S.M., Van Soolingen D. Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clin. Exp. Immunol. 2004, 137:460-468.
8. Flynn J.L., Chan J. What's good for the host is good for the bug. Trends Microbiol. 2005, 13:98-102.
9. Geffner L., Yokobori N., Basile J., Schierloh P., Balboa L., Romero M.M., Ritacco V., Vescovo M., Montaner P.G., López B., Barrera L., Alemán M., Abatte E., Sasiain M.C., de la Barrera S.S. Patients with multidrug resistant tuberculosis display impaired Th1 response and enhanced regulatory T cells levels in response to M and Ra outbreak multidrug resistant Mycobacterium tuberculosis strains. Infect. Immun. 2009, 77:5025-5034.
10. Harris P., Ralph P. Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. J. Leukoc. Biol. 1985, 37:407-422.
11. Henao J., Sánchez D., Muñoz C.H., Mejía N., Arias M.A., García L.F., Barrera L.F. Human splenic macrophages as a model for in vitro infection with Mycobacterium tuberculosis. Tuberculosis 2007, 87:509-517.
12. Hoal-van Helden E.G., Hon D., Lewis L.A., Beyers N., Van Helden P.D. Mycobacterial growth in human macrophages: variation according to donor, inoculum and bacterial strain. Cell Biol. Int. 2001, 25:71-81.
13. Homolka S., Niemann S., Russell D.G., Rohde K.H. Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival. PLoS Pathog. 2010, 6:e1000988.
14. Kamerbeek J., Schouls L., Kolk A., Van Agterveld M., Van Soolingen D., Kuijper S., Bunschoten A., Molhuizen H., Shaw R., Goyal M., Van Embden J. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 1997, 35:907-914.
15. Kang P.B., Azad A.K., Torrelles J.B., Kaufman T.M., Beharka A., Tibesar E., DesJardin L.E., Schlesinger L.S. The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. J. Exp. Med. 2005, 202:987-999.
16. Krishnan N., Malaga W., Constant P., Caws M., Tran T.H., Salmons J., Nguyen T.N., Nguyen D.B., Daffe M., Young D.B., Robertson B.D., Guilhot C., Thwaites G.E. Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles. PLoS ONE 2011, 6:e23870.
17. Li Q., Whalen C.C., Albert J.M., Larkin R., Zukowski L., Cave M.D., Silver R.F. Differences in rate and variability of intracellular growth of a panel of Mycobacterium tuberculosis clinical isolates within a human monocyte model. Infect. Immun. 2002, 70:6489-6493.
18. López B., Aguilar D., Orozco H., Burger M., Espitia C., Ritacco V., Barrera L., Kremer K., Hernández-Pando R., Huygen K., Van Soolingen D. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin. Exp. Immunol. 2003, 133:30-37.
19. Manca C., Tsenova L., Barry C.E., Bergtold A., Freeman S., Haslett P.A., Musser J.M., Freedman V.H., Kaplan G. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J. Immunol. 1999, 162:6740-6746.
20. Manca C., Reed M.B., Freeman S., Mathema B., Kremer K., Iii C.E.B., Kaplan G. Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infect. Immun. 2004, 72:5511-5514.
21. Marquina-Castillo B., García-García L., Ponce-de-León A., Jimenez-Corona M.-E., Bobadilla-Del Valle M., Cano-Arellano B., Canizales-Quintero S., Martinez-Gamboa A., Kato-Maeda M., Robertson B., Young D.B., Small P.M., Schoolnik G., Sifuentes-Osornio J., Hernández-Pando R. Virulence, immunopathology and transmissibility of selected strains of Mycobacterium tuberculosis in a murine model. Immunology 2009, 128:123-133.
22. Mathema B., Kurepina N., Yang G., Shashkina E., Manca C., Mehaffy C., Bielefeldt-Ohmann H., Ahuja S., Fallows D.A., Izzo A., Bifani P., Dobos K., Kaplan G., Kreiswirth B.N. Epidemiologic consequences of microvariation in Mycobacterium tuberculosis. J. Infect. Dis. 2012, 205:964-974.
23. Nau G.J., Richmond J.F., Schlesinger A., Jennings E.G., Lander E.S., Young R.A. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA 2002, 99:1503-1508.
24. Palmero D., Ritacco V., Ambroggi M., Marcela N., Barrera L., Capone L., Dambrosi A., di Lonardo M., Isola N., Poggi S., Vescovo M., Abbate E. Multidrug-resistant tuberculosis in HIV-negative patients, Buenos Aires, Argentina. Emerg. Infect. Dis. 2003, 9:965-969.
25. Paolo W.F., Nosanchuk J.D. Tuberculosis in New York city: recent lessons and a look ahead. Lancet Infect. Dis. 2004, 4:287-293.
26. Parwati I., Van Crevel R., Van Soolingen D. Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains. Lancet Infect. Dis. 2010, 10:103-111.
27. Portevin D., Gagneux S., Comas I., Young D. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog. 2011, 7:e1001307.
28. Rajaram M.V.S., Brooks M.N., Morris J.D., Torrelles J.B., Azad A.K., Schlesinger L.S. Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses. J. Immunol. 2010, 185:929-942.
29. Reed M.B., Domenech P., Manca C., Su H., Barczak A.K., Kreiswirth B.N., Kaplan G., Barry C.E. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004, 431:84-87.
30. Ritacco V., Di Lonardo M., Reniero A., Ambroggi M., Barrera L., Dambrosi A., López B., Isola N., de Kantor I.N. Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. J. Infect. Dis. 1997, 176:637-642.
31. Ritacco V., Iglesias M.J., Ferrazoli L., Monteserin J., Dalla Costa E.R., Cebollada A., Morcillo N., Robledo J., de Waard J.H., Araya P., Aristimuno L., Diaz R., Gavin P., Imperiale B., Simonsen V., Zapata E.M., Jimenez M.S., Rossetti M.L., Martin C., Barrera L., Samper S. Conspicuous multidrug-resistant Mycobacterium tuberculosis cluster strains do not trespass country borders in Latin America and Spain. Infect. Genet. Evol. 2012, 12:711-717.
32. Ritacco V., López B., Ambroggi M., Palmero D., Salvadores B., Gravina E., Mazzeo E., Network N.T.L., Imaz S., Barrera L. HIV infection and geographically bound transmission driving multidrug- and extensively drug-resistant tuberculosis in Argentina. Emerg. Infect. Dis. 2012, 18:1802-1810.
33. Schäfer G., Jacobs M., Wilkinson R.J., Brown G.D. Non-opsonic recognition of Mycobacterium tuberculosis by phagocytes. J. Innate Immun. 2009, 1:231-243.
34. Theus S.A., Cave M.D., Eisenach K.D. Activated THP-1 cells: an attractive model for the assessment of intracellular growth rates of Mycobacterium tuberculosis isolates. Infect. Immun. 2004, 72:1169-1173.
35. Theus S.A., Cave M.D., Eisenach K.D. Intracellular macrophage growth rates and cytokine profiles of Mycobacterium tuberculosis strains with different transmission dynamics. J. Infect. Dis. 2005, 191:453-460.
36. Theus S.A., Cave M.D., Eisenach K.D., Walrath J., Lee H., Mackay W., Whalen C., Silver R.F. Differences in the growth of paired Ugandan isolates of Mycobacterium tuberculosis within human mononuclear phagocytes correlate with epidemiological evidence of strain virulence. Infect. Immun. 2006, 74:6865-6876.
37. Theus S., Eisenach K., Fomukong N., Silver R.F., Cave M.D. Beijing family Mycobacterium tuberculosis strains differ in their intracellular growth in THP-1 macrophages. Int. J. Tuberc. Lung Dis. 2007, 11:1087-1093.
38. Tsenova L., Ellison E., Harbacheuski R., Moreira Andre.L., Kurepina N., Reed Michael.B., Mathema B., Barry Clifton.E.I., Kaplan G. Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. J. Infect. Dis. 2005, 192:98-106.
39. Valway S.E., Sanchez M.P., Shinnick T.F., Orme I., Agerton T., Hoy D., Jones J.S., Westmoreland H., Onorato I.M. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N. Engl. J. Med. 1998, 338:633-639.
40. Van Embden J.D., Cave M.D., Crawford J.T., Dale J.W., Eisenach K.D., Gicquel B., Hermans P., Martin C., McAdam R., Shinnick T.M., et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 1993, 31:406-409.
41. Wang C., Peyron P., Mestre O., Kaplan G., Van Soolingen D., Gao Q., Gicquel B., Neyrolles O. Innate immune response to Mycobacterium tuberculosis Beijing and other genotypes. PLoS ONE 2010, 5:e13594.
42. Yokobori N., Sabio y Garcia C.A., Geffner L., Schierloh P., Lopez B., Ritacco V., Barrera L., de la Barrera S., Sasiain M.C. Differential induction of macrophage cell death by antigens of a clustered and a non-clustered multidrug-resistant Mycobacterium tuberculosis strain from Haarlem family. FEMS Immunol. Med. Microbiol. 2012, 66:363-371.
43. Zhang M., Gong J., Yang Z. Enhanced Capacity of a Widespread Strain of Mycobacterium tuberculosis to Grow in Human Macrophages. J. Infect. Dis. 1999, 179:1213-1217.